IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by Deutsche Bank AG

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for cancer and rare diseases. The company's lead program, IDE-201, is a small molecule drug candidate in development for the treatment of pancreatic cancer.

Deutsche Bank AG is a multinational investment bank and financial services company headquartered in Frankfurt, Germany. The bank operates in various segments, including corporate banking, investment banking, asset management, and private wealth management.

According to IDEAYA Biosciences' most recent disclosure with the SEC, Deutsche Bank AG increased its holdings in the company by 15.7% during the 3rd quarter of 2021. The institutional investor owned 29,909 shares of the company's stock after acquiring an additional 4,054 shares during the quarter.

It is important to note that this information is based on the disclosure made by IDEAYA Biosciences and may be subject to change. It is always recommended to consult with a financial advisor for investment advice.